Cargando…
384. Denosumab-Related Osteonecrosis of the Jaw: an Emergent and Potentially Complex Bone and Joint Infection
BACKGROUND: Osteonecrosis of the jaw is a known complication of antiresorptive treatment, like bisphosphonate. More recently, denosumab was validated as a treatment in the osteoporosis and bone metastasis. Its mechanism is different from bisphosphonate but induces also a decrease of bone resorption...
Autores principales: | Bricca, Romain, Valour, Florent, Anne, Conrad, Braun, Evelyne, Jaby, Philippe, Bachelet, Jean-Thomas, Breton, Pierre, Gleizal, Arnaud, Laurent, Frederic, Chidiac, Christian, Ferry, Tristan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809727/ http://dx.doi.org/10.1093/ofid/ofz360.457 |
Ejemplares similares
-
Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019) -
Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022) -
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
por: Valour, Florent, et al.
Publicado: (2014) -
Bone and Joint Infection Involving Corynebacterium spp.: From Clinical Features to Pathophysiological Pathways
por: Chauvelot, Pierre, et al.
Publicado: (2021) -
Denosumab Related Osteonecrosis of Jaw: a Case Report
por: de Sales Lima, Marco Vinícius, et al.
Publicado: (2018)